CXI Finalizes Extraordinary Shareholder Meeting Agenda Including 5:1 Stock Split and Third-Party Capital Increase


  • CXI will hold an extraordinary general meeting on August 11, 2026, and the board has finalized the agenda.
  • Key items include the election of two independent directors, amendments to the articles of incorporation, a 5:1 stock split, and approval of a third-party capital increase.
  • While the stock split and capital increase may affect shareholder value, specific terms such as issue size and pricing have not been disclosed, resulting in a neutral near-term impact.
  • [AI Summary]CXI's finalization of the extraordinary shareholder meeting agenda includes structural changes like a stock split and capital increase, but the lack of disclosed details limits immediate stock price impact. Investors should monitor future announcements on pricing and scale.

KOSDAQ Filing Information


  • [Correction of Description] Resolution on Convening of General Meeting of Shareholders (Extraordinary General Meeting)
  • Company: CXI Healthcare Technology Group (900120)
  • Submission: CXI Healthcare Technology Group Limited
  • Under KRX KOSDAQ Market Division

  • Shares: 7,469,660
  • Price: 1,081 KRW
  • Market Cap: 8.1 B KRW